what are the survival rates for pancreatic cancer?

Q: what are the survival rates for pancreatic cancer?

In short The overall 5-year survival rate for pancreatic cancer is 12% [1]. This number is mostly driven by patients diagnosed with early, localized disease, whose survival rate has risen to 46% [1]. For most patients, the survival rate remains low because they are usually diagnosed at a later stage [1]. The details The overall 5-year survival rate for all pancreatic cancer patients is 12% [1]. This rate increased from 6% in 2004 to 12% in 2015 [1]. For patients with localized disease (cancer that has not spread), the 5-year survival rate rose from 24% to 46% between 2004 and 2015 [1]. Only about 14% of patients are diagnosed at this early, localized stage [1]. For patients with distant disease (cancer that has spread), the 5-year survival rate is very low, rising only from 2% to 3% during the same period [1]. Younger patients with early-onset pancreatic cancer may have better survival than older patients, but this finding needs more study [7]. What to know These statistics show that early detection is critical for better outcomes [1]. Most patients are diagnosed when the disease is already advanced or metastatic (spread to other parts of the body) [3]. New treatments are helping some patients live longer, especially in the short term, but long-term survival for advanced disease has not improved much yet [1]. These numbers are general trends and do not predict what will happen to any specific person.

Question

Accepted Answer

In short

The overall 5-year survival rate for pancreatic cancer is 12% [1]. This number is mostly driven by patients diagnosed with early, localized disease, whose survival rate has risen to 46% [1]. For most patients, the survival rate remains low because they are usually diagnosed at a later stage [1].

The details

The overall 5-year survival rate for all pancreatic cancer patients is 12% [1].

This rate increased from 6% in 2004 to 12% in 2015 [1].

For patients with localized disease (cancer that has not spread), the 5-year survival rate rose from 24% to 46% between 2004 and 2015 [1].

Only about 14% of patients are diagnosed at this early, localized stage [1].

For patients with distant disease (cancer that has spread), the 5-year survival rate is very low, rising only from 2% to 3% during the same period [1].

Younger patients with early-onset pancreatic cancer may have better survival than older patients, but this finding needs more study [7].

What to know

These statistics show that early detection is critical for better outcomes [1]. Most patients are diagnosed when the disease is already advanced or metastatic (spread to other parts of the body) [3]. New treatments are helping some patients live longer, especially in the short term, but long-term survival for advanced disease has not improved much yet [1]. These numbers are general trends and do not predict what will happen to any specific person.